Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zahra Jafariazar"'
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Due to the high and increasing economic burden of chronic diseases, including Multiple sclerosis (MS), we aimed to investigate the medical cost of MS in Iran. Methods This is a descriptive cross-sectional study which conducted usi
Externí odkaz:
https://doaj.org/article/8a0bd0f19b7d45d7ac85e9e9778e897f
Publikováno v:
Research Journal of Pharmacognosy, Vol 6, Iss 4, Pp 3-6 (2019)
Background and objectives: Garlic (Allium sativum L.) oil has been introduced in Iranian traditional medicine (ITM) as an effective topical agent for urine dribbling. Additionally, the beneficial effects of garlic on prostatic proliferation have been
Externí odkaz:
https://doaj.org/article/e1e6fb5e7818443e88b5c98a4b014671
Publikováno v:
Iranian Journal of Public Health.
Background: Due to the invariably progressive nature of multiple sclerosis (MS) and the high economic burden of chronic diseases, this study was performed to estimate the economic burden of MS medications in Iran. Methods: The present research is a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c73afd53e98dbfa27ecc85ab382b04
https://doi.org/10.18502/ijph.v52i2.11894
https://doi.org/10.18502/ijph.v52i2.11894
Autor:
Delaram Shayeganmehr, Fatemeh Ramezannia, Behrooz Gharib, Azin Rezaeilaal, Farhad Shahi, Zahra Jafariazar, Minoo Afshar
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology.
Hand-foot syndrome (HFS) can be categorized as a frequent dose-limiting side effect following administration of chemotherapeutic agents, which needs an effective medication to avoid dose reduction or discontinuation. Oral celecoxib has been proved to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f4331d4b42e970e17c82622a658d00
https://pubmed.ncbi.nlm.nih.gov/36418469
https://pubmed.ncbi.nlm.nih.gov/36418469
Publikováno v:
Cutaneous and Ocular Toxicology. 40:257-262
Purpose Hand-foot syndrome (HFS) is a frequent dose-limiting adverse reaction of fluoropyrimidine drugs like capecitabine and 5-flourouracil (5-FU) in breast and gastrointestinal cancers. It has been shown that conventional application of Lawsonia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d3fecbde5df55a5f4a37f4d8ee4c63c
https://doi.org/10.1080/15569527.2021.1940194
https://doi.org/10.1080/15569527.2021.1940194
Publikováno v:
Journal of Drug Delivery Science and Technology. 76:103726
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8664b630ec929a355c3d93ac2f19684e
https://doi.org/10.1016/j.jddst.2022.103726
https://doi.org/10.1016/j.jddst.2022.103726
Publikováno v:
MEDICAL SCIENCES JOURNAL. 29:117-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15c999035cada65a1914d263ce707195
https://doi.org/10.29252/iau.29.2.117
https://doi.org/10.29252/iau.29.2.117
Publikováno v:
Cutaneous and ocular toxicology. 40(3)
Hand-foot syndrome (HFS) is a frequent dose-limiting adverse reaction of fluoropyrimidine drugs like capecitabine and 5-flourouracil (5-FU) in breast and gastrointestinal cancers. It has been shown that conventional application ofThe topical dosage f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a12a1bcf905298515727df4f29da3f31
https://pubmed.ncbi.nlm.nih.gov/34152880
https://pubmed.ncbi.nlm.nih.gov/34152880
Autor:
Mahshid, Arabi, Seyed Alireza, Mortazavi, Zahra, Jafariazar, Hassan, Farhadnejad, Golnoosh, Alipour Harisa, Yousef, Fatahi
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
In this study, buccal mucoadhesive tablets of meloxicam were formulated for drug delivery as an alternative route. Direct compression method was applied for the preparation of tablets. Also, different polymers, including hydroxypropyl methyl cellulos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d5adcb7533014968062c5d11bb8f4ea
https://pubmed.ncbi.nlm.nih.gov/33680010
https://pubmed.ncbi.nlm.nih.gov/33680010
Publikováno v:
Marmara Pharmaceutical Journal. 22:267-276
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dd172859f1c21b8fc324f290f548faf
https://doi.org/10.12991/mpj.2018.64
https://doi.org/10.12991/mpj.2018.64